Skip to content
August 23, 2025

My Blog

  • Sample Page

Month: August 2025

FDA DMF Preparation & Filing for APIs, Excipients & Packaging – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on FDA DMF Preparation & Filing for APIs, Excipients & Packaging – XPRO America

A Drug Master File (DMF) is a confidential, detailed submission to the U.S. Food and Drug Administration (FDA) that provides information about the facilities, processes, and materials used in the…

| Tagged DMF cross reference, DMF maintenance support, DMF preparation services, DMF update services, Drug Master File, drug regulatory compliance, excipient DMF filing, FDA API compliance, FDA confidential filing, FDA DMF filing, FDA ESG submissions, FDA packaging DMF, FDA reference files, pharmaceutical regulatory services, Type II DMF, Type III DMF, Type IV DMF, Type V DMF, XPRO America DMF services

XPRO America – Controlled Substances Compliance (DEA & FDA)


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – Controlled Substances Compliance (DEA & FDA)

Compliance with controlled substances regulations is one of the most highly regulated areas in the U.S. pharmaceutical industry. Companies dealing with narcotics, psychotropics, or precursor chemicals must comply with both…

| Tagged ARCOS reporting, controlled drug scheduling, controlled substance diversion prevention, controlled substances compliance, controlled substances import export, controlled substances security, DEA FDA audit readiness, DEA FDA overlap, DEA FDA registration assistance, DEA FDA regulatory compliance, DEA Form 236, DEA Form 357, DEA inspection support, DEA registration support, DEA Schedule I-V guidance, FDA controlled drug labeling, FDA controlled substances, FDA drug compliance, XPRO America DEA FDA compliance

XPRO America – Clinical Trial IND Application & FDA Support Services


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – Clinical Trial IND Application & FDA Support Services

Launching a new drug in the United States requires rigorous compliance with FDA regulations, starting with the Investigational New Drug (IND) application. An IND is mandatory before beginning any clinical…

| Tagged clinical research IND, clinical trial IND filing, drug development IND, FDA clinical trial support, FDA IND submission, IND amendments, IND annual reports, IND application, IND CMC preparation, IND consulting, IND FDA communication, IND FDA services, IND maintenance, IND preclinical data support, IND preparation services, IND protocol design, IND regulatory compliance, Investigational New Drug, XPRO America IND services

FDA cGMP Compliance & 21 CFR 210/211 Audit Support – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on FDA cGMP Compliance & 21 CFR 210/211 Audit Support – XPRO America

Compliance with Current Good Manufacturing Practices (cGMP) is mandatory for all pharmaceutical manufacturers, repackers, relabelers, and distributors who want to market drug products in the United States. Governed under 21…

| Tagged 21 CFR 210, 21 CFR 211, cGMP compliance, cGMP quality system, cGMP training support, drug manufacturing compliance, drug quality control FDA, FDA audit readiness, FDA batch record compliance, FDA cGMP audits, FDA compliance consulting, FDA GMP inspection support, FDA manufacturing standards, FDA pharmaceutical audits, GMP documentation review, GMP gap analysis, GMP record keeping, pharmaceutical GMP compliance, XPRO America GMP services

XPRO America – FDA Annual & Ongoing Compliance Services for Drug Firms


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – FDA Annual & Ongoing Compliance Services for Drug Firms

For companies manufacturing, repacking, relabeling, or distributing human and veterinary drugs, annual and ongoing compliance with the U.S. Food and Drug Administration (FDA) is a mandatory responsibility. Non-compliance can lead…

| Tagged FDA annual compliance, FDA annual updates, FDA compliance consulting, FDA compliance documentation, FDA compliance partner, FDA compliance reviews, FDA compliance risk mitigation, FDA drug establishment renewal, FDA drug listing services, FDA drug listing updates, FDA enforcement prevention, FDA inspection readiness, FDA NDC updates, FDA ongoing compliance, FDA registration management, fda registration renewal, FDA regulatory monitoring, FDA regulatory updates, FDA SPL submissions

XPRO America – ANDA Bioequivalence (BE/BA) Studies & CRO Coordination


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – ANDA Bioequivalence (BE/BA) Studies & CRO Coordination

To bring a generic drug to the U.S. market, sponsors must file an Abbreviated New Drug Application (ANDA) with the FDA. A key requirement of the ANDA process is proving…

ANDA & NDA Submissions Support for FDA Drug Approvals – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on ANDA & NDA Submissions Support for FDA Drug Approvals – XPRO America

Bringing a pharmaceutical product to the U.S. market requires rigorous regulatory approval by the U.S. Food and Drug Administration (FDA). For drug manufacturers, this process involves filing either an Abbreviated…

| Tagged ANDA regulatory support, ANDA submission support, eCTD compilation FDA, FDA ANDA services, FDA bioequivalence study, FDA clinical data submission, FDA drug application support, FDA drug approval consulting, FDA drug compliance services, FDA drug labeling compliance, FDA eCTD publishing, FDA NDA services, FDA pharma submissions, FDA preclinical support, FDA regulatory consulting, generic drug FDA approval, NDA regulatory guidance, NDA submission services, novel drug FDA approval

FDA Voluntary Cosmetic Registration Program (VCRP) Support – XPRO America


Posted on August 20, 2025 | Posted on admin | Leave a Comment on FDA Voluntary Cosmetic Registration Program (VCRP) Support – XPRO America

The Voluntary Cosmetic Registration Program (VCRP) is an FDA-operated electronic system designed for cosmetic product establishments and formulation listings in the United States. While registration under VCRP is not mandatory,…

| Tagged FDA cosmetic compliance, FDA cosmetic distributor registration, FDA cosmetic establishment listing, FDA cosmetic formulation listing, FDA cosmetic ingredient listing, FDA cosmetic manufacturer registration, FDA cosmetic market access, FDA cosmetic MoCRA compliance, FDA cosmetic packer registration, FDA cosmetic product database, FDA cosmetic registration, FDA cosmetic regulation support, FDA cosmetic regulatory consultant, FDA cosmetic transparency program, FDA VCRP, FDA VCRP registration service, FDA voluntary compliance cosmetics, FDA voluntary registration cosmetics, Voluntary Cosmetic Registration Program

FDA US Agent Services for Foreign Cosmetic Facilities – XPRO America


Posted on August 20, 2025 | Posted on admin | Leave a Comment on FDA US Agent Services for Foreign Cosmetic Facilities – XPRO America

For foreign cosmetic companies seeking access to the U.S. market, appointing a U.S. Agent is not optional it is a mandatory requirement under FDA regulations. Any cosmetic facility located outside…

| Tagged FDA communication representative, FDA cosmetic compliance, FDA cosmetic compliance consultant, FDA cosmetic export to USA, FDA cosmetic facility registration support, FDA cosmetic inspection readiness, FDA cosmetic inspection support, FDA cosmetic regulation compliance, FDA foreign cosmetic manufacturer agent, FDA foreign facility US Agent, FDA import compliance cosmetics, FDA market entry cosmetics, FDA MoCRA US Agent services, FDA regulatory communication agent, FDA US Agent 24/7 support, FDA US Agent appointment, FDA US Agent requirement, FDA US Agent services, US Agent for foreign cosmetic companies

FDA Cosmetic Product Recall & Enforcement Guidance – XPRO America


Posted on August 20, 2025 | Posted on admin | Leave a Comment on FDA Cosmetic Product Recall & Enforcement Guidance – XPRO America

In the highly regulated U.S. cosmetics market, even established brands may face situations where products must be withdrawn due to safety concerns, misbranding, or contamination. Under the Modernization of Cosmetics…

| Tagged FDA adulterated cosmetic recall, FDA cosmetic brand recall support, FDA cosmetic compliance consultant, FDA cosmetic corrective action, FDA cosmetic crisis management, FDA cosmetic enforcement support, FDA cosmetic misbranding recall, FDA cosmetic recall consultant, FDA cosmetic recall guidance, FDA cosmetic recall procedure, FDA cosmetic safety recall, FDA MoCRA recall compliance, FDA product recall liaison, FDA product withdrawal cosmetics, FDA recall compliance cosmetics, FDA recall plan cosmetics, FDA recall risk assessment cosmetics, FDA recall strategy cosmetics, FDA voluntary recall cosmetics

Posts pagination

Previous 1 … 3 4 5 Next

Recent Posts

  • US FDA FCE & SID Registration – XPRO AMERICA
  • US FDA Compliance for Dietary Supplements & Nutraceuticals – XPRO AMERICA
  • US FDA GRAS & Food Additive Consultation – XPRO AMERICA
  • US FDA Importer Assistance for FSVP Compliance – XPRO AMERICA
  • FDA Inspection & Audit Readiness – XPRO AMERICA

Recent Comments

No comments to show.

Archives

  • August 2025
  • July 2024
  • October 2023
  • September 2023
  • July 2023

Categories

  • Uncategorized
About Us

Nam malesuada nulla nisi, ut faucibus magna congue nec. Ut libero tortor, tempus at auctor in, molestie at nisi. In enim ligula, consequat eu feugiat a.

Useful Links
  • Home
  • services
  • Reviews
  • About Us
Information
  • FAQ
  • Site Maps
  • Privacy Policy
  • Contact Us
Get In Touch
  • Via Carlo Montù 78
    22021 Bellagio CO, Italy
  • +11 6254 7855
  • support@example.com
Proudly powered by WordPress | Viral News WordPress Theme by TheMagnifico.